Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05046158 · ClinicalTrials.gov registry record · NA
Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care
A NA study of Diabetic Foot Ulcer, sponsored by ULURU.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
- 12
- Study locations
NCT05046158: Completed NA study of Diabetic Foot Ulcer, sponsored by ULURU.
NCT05046158 is a NA study of Diabetic Foot Ulcer that has completed, run by ULURU. The registered enrollment target is 135 participants, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (47% lower). The trial reports 12 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05046158, a NA study of Diabetic Foot Ulcer, has completed, sponsored by ULURU.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
- 12
- Study locations
Study Summary
Phase IV, randomized, prospective, multi-center, open-label, comparison of transforming powder dressing to standard of care dressing for healing diabetic foot ulcers.
Primary Outcome
Compare rate of complete wound healing in diabetic foot wounds between the two study groups
Conditions Studied
Interventions
- DEVICE Transforming Powder Dressing
- OTHER Standard of care topical wound agents and dressings
Study Locations (12)
New York
- Northwell Health Wound Healing Center - Lake Success
- Bronx Foot Care - The Bronx
- James J. Peters VA Medical Center - The Bronx
- VA Hudson Valley HealthCare System - Wappingers Falls
Maryland
- VA Maryland Health Care System - Baltimore
- MedStar Good Samaritan Hospital - Baltimore
- MedStar Franklin Square - Rossville
District of Columbia
- MedStar Georgetown University Hospital - Washington D.C.
- MedStar Washington Hospital Center - Washington D.C.
Texas
- Dallas Veteran's Administration Medical Center - Dallas
- Baylor College of Medicine Clinic Hospital McNair (MDHP) BCM390 - Houston
Florida
- AdventHealth Medical Group Foot & Ankle at Winter Park - Winter Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2025-11-06 |
| Phase | NA |
What the finished NCT05046158 record still lists
NCT05046158 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Transforming Powder Dressing is the first listed.
NCT05046158 lists 12 locations in 5 states (New York, Maryland, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT05046158 about?
NCT05046158 is a clinical study titled "Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care". Phase IV, randomized, prospective, multi-center, open-label, comparison of transforming powder dressing to standard of care dressing for healing diabetic foot ulcers.
What is the current status of trial NCT05046158?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2021-08-16. Estimated completion is 2025-11-06.
What conditions does trial NCT05046158 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer.
What interventions are being tested in trial NCT05046158?
The interventions under investigation include: Transforming Powder Dressing (DEVICE), Standard of care topical wound agents and dressings (OTHER).
Who is sponsoring clinical trial NCT05046158?
This trial is sponsored by ULURU, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05046158 being conducted?
This trial has 12 study locations across District of Columbia, Florida, Maryland, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05046158's enrollment target sits among peer trials
135 28th of 67 higher than 40 of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI